Key result
Clinical-biochemical model accurately predicts stroke risk in type 2 diabetes with ~0.89 C-index.
Observational (n=4,335)
Purpose: Stroke has sparked global concern as it seriously threatens people’s life, bringing about dramatic health burdens on patients, especially for type 2 diabetes mellitus (T2DM) patients. Therefore, a risk scoring model is urgently valuable for T2DM patients to predict risk of stroke incidence and for positive health intervention. Methods: We randomly divided 4335 T2DM patients into two groups, training set (n=3252) and validation set (n=1083) at the ratio of 3:1. Characteristic variables were then selected based on the data of training set through least absolute shrinkage and selection operator (LASSO) regression. Three models were established to verify predictive ability. Foundation model was composed of basic information and physical indicators. Biochemical model consisted of biochemical indexes. Integrated model combined the above two models. Data of three models were then put into logistic regression analysis to form nomogram prediction models. Tools including C-index, calibration plot, curve analysis were implemented to test discrimination, calibration, and clinical use. To select the best predicting model, Net Reclassification Improvement (NRI) and Integrated Discrimination Improvement (IDI) were put into effect. Results: 11 risk factors were determined, including Age, duration of T2DM, Glomerular Filtration Rate, Systolic Blood Pressure, Diastolic Blood Pressure, Low-density Lipoprotein, High-density Lipoprotein, Triglyceride, Body Mass Index, Uric Acid, Glycosylated Haemoglobin A1c, all with significant P-values through logistic regression analysis. In the training set, AUC of three models were 0.810, 0.819 and 0.884 while in the validation set were 0.836, 0.832 and 0.909. Through calibration plot, the S:P values in the training set were 0.836, 0.754 and 0.621 and were 0.918, 0.682 and 0.666 separately in the validation set. In terms of the decision curve analysis, the risk thresholds were respectively 8%-73%, 8%-98%, and 8%~ in the training set and 8%-70%, 8%-90%, and 8%-95% in the validation set. With the aid of NRI and IDI, integrated model is proved to be the best model in training set and validation set. Besides, internal validation was conducted on all the subjects in this study and the C-index was 0.890(0.873-0.907). Conclusion: This study established a model predicting risk of stroke for T2DM patients through a community-based survey.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2020) conducted an observational in Type 2 diabetes mellitus (n=4,335). Integrated risk prediction model vs. Foundation model and biochemical model was evaluated on Prediction of stroke risk (C-index) (C-index 0.890, 95% CI 0.873-0.907). An integrated prediction model combining basic clinical information and biochemical indexes effectively predicted stroke risk in type 2 diabetes patients (overall C-index 0.890; 95% CI 0.873-0.907).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: